+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 60Years +
All Genders
ID07531927

Safety and Clinical Applicability of Transcorneal Electrical Stimulation TES in Geographic Atrophy Under Everyday Conditions - a Multicentric, Randomized, Double-masked, Sham-controlled Pilot Study

Led by Okuvision GmbH · Updated on 2026-07-28

70

Participants Needed

5

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Geographic atrophy GA is a progressive eye disease that damages retinal cells in the macula, causing vision loss. This pilot study is designed to assess the safety and potential effectiveness of transcorneal electrical stimulation TES therapy using the OkuStim 2 System in people with GA. Researchers aim to compare two different electrical stimulation patterns against a placebo to determine if they are safe and can slow disease progression. Participants will be randomly divided into three groups one receiving TES with a rectangular stimulus, another receiving TES with a repetitive ramp stimulus, and a placebo group receiving sham stimulation. After initial training, participants will apply the therapy at home once a week for 30 minutes over a year, treating only one eye. The stimulation uses specific electrical parameters to avoid discomfort and maintain consistent therapy. During the trial, participants will undergo regular assessments including imaging and vision tests to monitor changes in GA lesion areas, retinal structure, and visual acuity under normal and low light. Patient-reported outcomes will also be collected to evaluate the therapys impact on daily life and usability. Safety of TES therapy will be monitored throughout the 52-week study period, with visits scheduled at several points to track progress and effects.

CONDITIONS

Brief Title

Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy

Research Team

R

Ruth Schippert, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here